The suprachiasmatic nucleus (SCN) of the hypothalamus is the principal circadian pacemaker in mammals, coordinating daily metabolic and physiological rhythms with the cycle of sleep and wakefulness ([@bibr26-0748730414520663]). In common with other tissues, SCN neurons define circadian time via an auto-regulatory feedback loop in which the *Period* (*Per*) and *Cryptochrome* (*Cry*) genes are first activated by CLOCK-BMAL1 heterodimers acting at E-box enhancer sequences, then subsequently suppressed by their own protein products ([@bibr20-0748730414520663]; [@bibr12-0748730414520663]). Casein kinase 1 (CK1) enzymes have a critical role in circadian pacemaking because they phosphorylate PER proteins and thereby direct their proteasomal degradation ([@bibr13-0748730414520663]; [@bibr7-0748730414520663]). Individual mutations in either hCK1 or hPER2 lead to advanced sleep phase disorders ([@bibr10-0748730414520663]; [@bibr28-0748730414520663]; [@bibr31-0748730414520663]), whereas in rodents the *Tau* mutation of CK1 epsilon (*CK1*ϵ^*Tau*^) accelerates rest-activity cycles and shortens the period of the SCN molecular pacemaker ([@bibr25-0748730414520663]; [@bibr15-0748730414520663]; [@bibr18-0748730414520663]). Biochemical analyses of recombinant PER proteins in cultured cells and endogenous proteins in peripheral tissues ex vivo have identified PER1 and PER2, but not PER3, as direct substrates of CK1ϵ ([@bibr13-0748730414520663]). The purpose of the current study, therefore, was to complement and extend this earlier work by examining the real-time dynamics of circadian pacemaking and determining the relative contributions of endogenous PER proteins to the period-accelerating effects of CK1ϵ^*Tau*^. Specifically, the aim was to examine the effects of CK1ϵ^*Tau*^ at 2 levels: the rest-activity cycle of the whole animal and the molecular feedback loop of the SCN in culture, as revealed by rhythms of bioluminescence. A related study uncovered distinct and separable contributions of endogenous CRY1 and CRY2 to pacemaking in vivo and in vitro ([@bibr1-0748730414520663]). The question here was whether similarly distinct roles for PER1 and PER2 might be revealed, and whether more dynamic measures of pacemaking at the level of SCN slices and individual neurons might identify a contribution of PER3 to the effects of CK1ϵ^*Tau*^. Such information would add to the growing understanding of how different elements within gene families (e.g., NPAS and CLOCK \[[@bibr5-0748730414520663]\], and REV-ERBa and REV-ERBb \[[@bibr4-0748730414520663]\]) sculpt circadian behavior and physiology.

Materials and Methods {#section1-0748730414520663}
=====================

All experiments with animals were licensed under the UK Animals (Scientific Procedures) Act of 1986 and subject to local ethical review. Mice lacking *Per1* or *Per2* ([@bibr2-0748730414520663]) were obtained from Dr. D. Weaver (University of Massachusetts Medical School, USA). The *Per1-luciferase* (*Per1-luc*) bioluminescent reporter line ([@bibr32-0748730414520663]) was provided by Dr. H. Okamura (University of Kyoto, Japan), and the CK1ϵ^*Tau*^ line ([@bibr18-0748730414520663]) was obtained from our own colony. The various lines, all on a C57Bl6 background and after at least 8 back-crosses prior to the current studies, were intercrossed to generate the required genotypes, all of which carried the *Per1-luc* reporter. Genotyping by PCR followed the methods published in the respective original descriptions of these mouse lines ([@bibr32-0748730414520663]; [@bibr18-0748730414520663]; [@bibr2-0748730414520663]).

Wheel-running activity of single-housed adult male mice (aged between 8 and 20 weeks) was recorded and analyzed with Clocklab (Actimetrics, Evanston, IL, USA). Organotypic SCN slice cultures were prepared as described ([@bibr9-0748730414520663]) from pups aged between 5 and 13 days. Slices were held in culture for at least 1 week (and up to 3 weeks) prior to recording bioluminescence rhythms, either by photomultiplier tube (PMT) for whole-slice emission or by charge-coupled device (CCD) camera to monitor circadian gene expression by individual cells in the intact SCN ([@bibr17-0748730414520663]). The parameters of the bioluminescence rhythms (period, amplitude, and relative amplitude error \[RAE\], a measure of coherence of the rhythm, were determined using Biological Rhythms Analysis Software System (BRASS) software running on BioDARE, courtesy of Prof. A. Millar, University of Edinburgh, UK; see [www.biodare.ed.ac.uk](http://www.biodare.ed.ac.uk) for details). Circular data were analyzed using Oriana Software (Kovach Computing Services, UK). The data from the initial 24 h of recording were not included in the analysis to avoid potential artifacts arising from transfer of the slice to fresh medium and a recording chamber. Rhythm phase was calculated relative to the start of this data set.

Results {#section2-0748730414520663}
=======

Behavioral Rhythms {#section3-0748730414520663}
------------------

Wild-type (WT) mice presented very clear and stable rhythms of wheel-running behavior ([Fig. 1A](#fig1-0748730414520663){ref-type="fig"}). The loss of either PER1 or PER2 did not compromise circadian behavior; all mice of both mutant lines exhibited rhythms with a quality indistinguishable from that of WT mice. In contrast, all double-mutant mice lacking both PER1 and PER2, with otherwise WT or *Tau* backgrounds (*n* = 4, 4), were unable to express circadian behavior. Rather, sporadic activity bouts were distributed among all time points, and they lacked the consolidation and coherence typical of WT and single-null mice. Thus, periodogram analysis did not generate significant peaks in the circadian domain, indicating that PER1 and PER2 are necessary but mutually redundant clock components.

![The *Tau* mutation of CK1 epsilon (CK1ϵ^*Tau*^) shortens circadian locomotor activity rhythms in *Period-1* (*Per1-*) and *Per2-*null mice. (A) Representative actograms, recorded under continuous dim red light, of wild-type (WT) and CK1ϵ^*Tau/Tau*^ mutant mice with homozygous *Per1-*null, *Per2-*null, and *Per1*-*Per2* (*Per1/2*)*-*null backgrounds. (B) Free-running circadian period of WT, CK1ϵ^*Tau/Tau*^ mutant, and Per-deficient mice, as in (A) (group data, mean + standard error of the mean). Note that no circadian behavior was detected in *Per1/2* double-null mice. \*\**p* \< 0.01 versus corresponding *Tau* WT, ANOVA, and Tukey post hoc.](10.1177_0748730414520663-fig1){#fig1-0748730414520663}

The free-running circadian period of wheel-running behavior was shortened by 4 h in mice homozygous for the *Tau* mutation with an otherwise WT background (*Tau* WT period = 24.1 + 0.1 h \[mean + standard error of the mean {SEM}\]; *Tau* homo = 20.1 + 0.1 \[*n* = 23, 14\]) ([Fig. 1B](#fig1-0748730414520663){ref-type="fig"}). Comparison by 2-way ANOVA of circadian periods in PER1 and PER2 single-mutant mice, with and without *Tau* (*Per1-*null *n* = 14, 13; *Per2-*null *n* = 10, 12), revealed a highly significant effect of *Tau* (F~1,80~ = 1909, *p* \< 0.001) but not of *Per* genotype (F~2,80~ = 0.099, *p* = 0.91). There was, however, a significant interaction between *Tau* and *Per* genotypes (F~2,80~ = 11, *p* \< 0.001). This interaction arose because the period-shortening effects of *Tau* were different among *Per* backgrounds. In *Per1-*null mice, *Tau* accelerated behavior by 3.2 h (23.8 + 0.1 vs. 20.6 + 0.1 h), whereas in *Per2-*null mice, the acceleration was 3.5 h (23.9 + 0.1 vs. 20.4 + 0.3 h). The impact of *Tau* was therefore attenuated by loss of either PER1 or PER2, but there was no significant difference of circadian period between *Per1-* and *Per2-*null mice carrying *Tau*. Thus, both PER1 and PER2 are comparable in vivo targets of *Tau*.

Circadian Pacemaking in PER1- and PER2-Deficient SCN Slices {#section4-0748730414520663}
-----------------------------------------------------------

The circadian rhythms of bioluminescence reported by the *Per1-luc* transgene in WT SCN slices were very clear and precise ([Fig. 2A](#fig2-0748730414520663){ref-type="fig"}). Equally robust rhythms were evident in *Tau* WT slices lacking either PER1 or PER2. In SCN homozygous for the *Tau* mutation with an otherwise WT background, the circadian period of SCN was shortened by 3.7 h (WT period = 24.6 + 0.1 h; *Tau* homo = 20.9 + 0.2 \[*n* = 36, 28\]) ([Fig. 2B](#fig2-0748730414520663){ref-type="fig"}). Comparison by 2-way ANOVA of circadian periods in *Per1* and *Per2* single-mutant mice, with and without *Tau* (*Per1-*null *n* = 17, 9; *Per2-*null *n* = 17, 28), revealed a highly significant effect of *Tau* (F~1,129~ = 582, *p* \< 0.001) but not of *Per* genotype (F~2,129~ = 1.90, *p* = 0.15), although there was a significant interaction between *Tau* and *Per* genotypes (F~2,129~ = 7.60, *p* \< 0.001). This interaction arose because the period-shortening effect of *Tau* was different according to *Per* background. In *Per1-*null SCN, *Tau* accelerated the clock by 4.5 h (24.6 + 0.1 vs. 20.1 + 0.2 h), whereas in *Per2-*null SCN, the acceleration was 2.9 h (24.1 + 0.1 vs. 21.2 + 0.1 h). The impact of *Tau* was therefore affected by loss of either PER1 or PER2, and in a PER2-dependent clock (i.e., *Per1-*null), *Tau* caused a greater acceleration than in a PER1-dependent (*Per2-*null) clock. Thus, the period of *Per1-*null--*Tau* homozygous SCN was significantly (*p* \< 0.01, Bonferroni post hoc) shorter than that of the corresponding *Per2-*null SCN, even though there were no significant differences in the periods of *Tau* WT slices among the *Per* backgrounds. At the level of the SCN, therefore, both PER1 and PER2 are mediators of the period-shortening effect of *Tau*, with a greater contribution from PER2.

![The *Tau* mutation of CK1 epsilon (CK1ϵ^*Tau*^) shortens circadian *Period1-luciferase* (*Per1-luc*) bioluminescence rhythms in *Per1-* and *Per2-*null suprachiasmatic nucleus (SCN) slices. (A) Representative recordings by photomultiplier tube (PMT) of bioluminescence rhythms from wild-type (WT) (black) and CK1ϵ^*Tau/Tau*^ mutant (gray) SCN with *Per* WT, *Per1-*null, or *Per2-*null backgrounds. (B) Free-running circadian period of bioluminescence rhythms from WT, CK1ϵ^*Tau/Tau*^ mutant, and *Per*-deficient SCN, as in (A) (group data, mean + standard error of the mean). \*\**p* \< 0.01 versus corresponding *Tau* WT, \~*p* \< 0.05 versus *Per2-*null, *Tau* homozygote, ANOVA, and Tukey post hoc.](10.1177_0748730414520663-fig2){#fig2-0748730414520663}

Circadian Pacemaking in SCN Slices Deficient in Both PER1 and PER2 {#section5-0748730414520663}
------------------------------------------------------------------

Mice lacking PER1 and PER2 were behaviorally arrhythmic. In generating such mice for SCN studies, slices were created that carried a single copy of either *Per1* or *Per2*. A single *Per* allele was nevertheless sufficient to sustain a functional SCN clock, with a mean period of 23.8 + 0.4 h (*n* = 8) and amplitude of 775 + 310, neither significantly different from WT slices with 4 *Per* alleles (period of 24.6 + 0.1 h; amplitude = 839.5 + 219; *n* = 9). Their coherence was, however, significantly reduced in SCN with a single copy of *Per* (WT RAE = 0.036 + 0.004; single *Per* RAE = 0.068 + 0.011; *p* \< 0.05 *t*-test). The presence of only a single *Per* allele did not make the SCN more sensitive to the homozygous *Tau* mutation (Period: *Per* WT = 20.6 + 0.4; single *Per =* 19.8 + 0.3 h, *n* = 7, 6). Because the single *Per* alleles were distributed unevenly among *Tau* backgrounds (the *Tau* WT group contained one *Per2* heterozygote and 7 *Per1* heterozygotes; the *Tau* homozygote group contained one *Per1* heterozygote and 5 *Per2* heterozygotes), it is not possible to make an assessment of their differential contributions. Nevertheless, the available data suggest that in the interaction between *Tau* and PER1/2 (for these purposes, they are considered equivalent), there was no obvious dose dependence or sensitivity to the ratio of their relative expression.

In contrast to the clear rhythms in slices carrying one *Per* allele, SCN slices completely lacking both PER1 and PER2 exhibited very poorly organized rhythms of *Per1-luc* bioluminescence, consistent with the behavioral arrhythmicity of *Per1*-*Per2* (*Per1/2*) double-null mice ([Fig. 3A](#fig3-0748730414520663){ref-type="fig"}). Closer examination did, however, reveal transient oscillations during the first few days of recording that immediately followed transfer of the slices to fresh recording medium ([Fig. 3B](#fig3-0748730414520663){ref-type="fig"}). These tended to have a shorter period than wild-type slices but not significantly so (*Per1/2*-null = 22.0 + 1.6 h, *n* = 7, assessed during hours 24-96) ([Fig. 3C](#fig3-0748730414520663){ref-type="fig"}). There was, however, a significantly greater incoherence (RAE = 0.147 + 0.099, *p* \< 0.01 *t*-test) in the *Per*-null oscillations, and they progressively damped out. Although the overall level of *Per1-luc* bioluminescence was not significantly lower, the amplitude of oscillation was \< 10% of the WT slices (50.8 + 18, *p* \< 0.05 *t*-test). This reduction is too great to be accounted for by unequal segregation of hemizygous and homozygous reporter animals among genotypes: rather, it reflects a major loss of circadian control.

![Compromised ensemble molecular pacemaking in *Period 1* (*Per1*)- and *Per2-*null (*Per1/2*-null) suprachiasmatic nucleus (SCN), revealed by *Per1-luciferase* (*Per1-luc*) bioluminescence recording. (A) Representative bioluminescence recording by photomultiplier tube (PMT) of wild-type (WT) (black) and *Per1/2-*null (gray) SCN. (B) Three representative recordings from *Per1/2-*null SCN rescaled to reveal transient, short-period ensemble oscillations. The maximum value of the individual recording was scaled to 100, and all other counts were rescaled accordingly (i.e., % maximum). (C) Circadian parameters, determined by Biological Rhythms Analysis Software System fast Fourier transform (BRASS-FFT) of *Per1*/*2* WT control SCN, and SCN deficient in PER1 and PER2, with WT or CK1ϵ^*Tau*^ alleles (group data, mean + standard error of the mean). n.s., not significantly different; \**p* \< 0.05; \*\**p* \< 0.01 versus control WT SCN (ANOVA and Tukey post hoc).](10.1177_0748730414520663-fig3){#fig3-0748730414520663}

Importantly, the period of the transient oscillation in *Per1/2*-null SCN was not significantly affected by the presence of one or two copies of the *Tau* allele (*Tau* Het = 19.3 + 0.8, Homo = 20.6 + 1.0 h, *n* = 7, 9) ([Fig. 3C](#fig3-0748730414520663){ref-type="fig"}). Thus, the *Tau* mutation requires the presence of at least one copy of *Per1* or *Per2* to affect the period of the SCN clockwork. In addition, whatever the nature of the mechanism underlying the transient oscillations present in *Per1/2*-null SCN, it is not sensitive to *Tau*.

Cellular Circadian Pacemaking in SCN Slices Deficient in Both PER1 and PER2 {#section6-0748730414520663}
---------------------------------------------------------------------------

Deletion of *Bmal1* or both *Cry* genes renders mice behaviorally arrhythmic and compromises bioluminescence rhythms in the SCN, similar to the effect of *Per1/2* deletion seen here. Nevertheless, at the level of individual cells imaged in SCN slices by CCD camera, ongoing oscillations in the circadian range can be detected in these mutants, albeit with poor synchrony throughout the SCN circuit. Oscillatory behavior was therefore tested in single cells of *Per1/2* double-null SCN. As noted in this article with PMT recordings, the ensemble rhythm of *Per1/2*-null SCN was poorly defined relative to WT controls (RAE WT = 0.082 + 0.022, *Per1/2* double null = 0.588 + 0.044, *n* = 3, 6), and the period tended to be shorter than that of WT slices (WT 24.3 + 0.5 h, double-null 21.2 + 3.1 h). Poorly defined ensemble rhythms were also detected by bioluminescent imaging in *Per1/2*-null SCN with a single or two copies of *Tau* (RAE Het = 0.414 + 0.076, Homo = 0.446 + 0.079, *n* = 2 \[one slice failed fast Fourier transform, or FFT\], 3). The period of these residual rhythms was not significantly shortened by one or two copies of the *Tau* allele (*Tau* het 28.3 + 1.3 h, *Tau* homo 25.4 + 4.6 h, *n* = 2, 3). In *Per1/2* WT slices, *Per1-luc* bioluminescence emission was identifiable from a large number of individual cells (\>150 per slice, *n* = 3 slices) ([Fig. 4A](#fig4-0748730414520663){ref-type="fig"} and [4B](#fig4-0748730414520663){ref-type="fig"}). In *Per1/2-*null SCN with a wild-type *Tau* background (*n* = 6 slices), a similar number of bioluminescent cells could be identified, but whereas BRASS analysis was able to fit a rhythm of a broadly circadian period (15-35 h) in circa 96.0 + 2.6% of cells in control slices, this fell significantly to 34.1 + 5.6% in the *Per1/2-*null slices ([Table 1](#table1-0748730414520663){ref-type="table"}). The mean period of the *Per1/2-*null cells was not significantly different from that of cells in control slices ([Table 1](#table1-0748730414520663){ref-type="table"}), but the coefficient of variance of period (a measure of how variable the period is during the recording, determined by BRASS) within *Per1/*2-null slices was significantly higher ([Table 1](#table1-0748730414520663){ref-type="table"}). Furthermore, the phase distribution of the rhythmic cells, assessed by Rayleigh plots, was significantly greater in the null mutant SCN ([Fig. 4C](#fig4-0748730414520663){ref-type="fig"} and [Table 1](#table1-0748730414520663){ref-type="table"}), which is indicative of poor synchrony throughout the circuit. Thus, molecular circadian pacemaking can arise spontaneously in individual neurons of *Per1/*2-null SCN, although it is poorly organized within cells, has comparatively low amplitude, and lacks synchrony throughout the slice.

![Cellular molecular pacemaking in *Period1* and *Period2* (*Per1/2*)-null suprachiasmatic nucleus (SCN), as revealed by *Per1-luciferase* (*Per1-luc*) bioluminescence rhythms, is not sensitive to the *Tau* mutation of casein kinase 1 epsilon (CK1ϵ^*Tau*^). (A) Representative raster (above) and graphical (below) plots of bioluminescence recordings of individual cells from *Per1*/*2* wild-type (WT) control and *Per1/2-*null SCN. Note the disorganization in the *Per1/2-*null slice. (B) Representative recordings from individual SCN cells from control, and *Per1/2-*null SCN without (WT) or with (homo) the CK1ϵ^*Tau*^ allele. (C) Representative Rayleigh plots of cellular bioluminescence rhythms recorded from WT control and *Per1/2-*null SCN, without or with CK1ϵ^*Tau*^ (het, homo) (*n* = 156, 61, 45, and 25, respectively).](10.1177_0748730414520663-fig4){#fig4-0748730414520663}

###### 

Circadian analysis of *Period1-luciferase* (*Per1-luc*) bioluminescence rhythms of individual cells in *Per1* and *Per2* wild-type (WT) control and *Per1/2*-null suprachiasmatic nucleus (SCN) slices, the latter with WT, heterozygous, or homozygous *Tau* backgrounds. The mean value is the mean of the individual slice values (*n*). For each individual slice, a large number (ca. \>150) of cells was analyzed. \**p* \< 0.05; \*\**p* \< 0.01 versus control slices; Tukey multiple-comparison test.

                                                                           WT controls (*n* = 3)   *Per*-null *Tau* WT (*n* = 6)   *Per*-null *Tau* het (*n* = 3)   *Per*-null *Tau* homo (*n* = 3)   *p* value (ANOVA)
  ------------------------------------------------------------------------ ----------------------- ------------------------------- -------------------------------- --------------------------------- -------------------
  Fast Fourier transform pass rate, % + standard error of the mean (SEM)   96.0 + 2.6              34.1 + 5.6\*\*                  32.1 + 9.6\*\*                   45.0 + 18.0\*                     \<0.01
  Period, h + SEM                                                          24.7 + 0.2              27.5 + 1.0                      25.5 + 1.4                       25.5 + 1.3                        0.30; n.s.
  Period variance + SEM                                                    2.0 + 0.8               23.5 + 4.1\*                    20.5 + 1.1                       34.1 + 14.9\*                     0.03
  Relative amplitude error                                                 0.18 + 0.07             0.67 + 0.04\*\*                 0.70 + 0.03\*\*                  0.63 + 0.05\*\*                   \<0.01
  Amplitude                                                                13.4 + 6.1              2.3 + 0.9\*                     2.5 + 0.6                        4.3 + 1.3                         0.04
  Rayleigh mean vector + SEM                                               0.92 + 0.02             0.16 + 0.05\*\*                 0.31 + 0.15\*                    0.20 + 0.07\*\*                   \<0.01
  Rayleigh *p* value (mean)                                                1\*E−12                 0.4108                          0.1636                           0.2497                            

The effect of the *Tau* allele on cellular circadian bioluminescence rhythms was then examined in *Per1/2-*null SCN. As with the *Tau* wild-type slices, bioluminescent cells were identified in *Tau* heterozygous and homozygous SCN, although only a minority were identified as rhythmic by BRASS analysis (32.1 + 9.6% and 45.0 + 18%, respectively; *n* = 3 for both). Again, these rhythmic cells were highly asynchronous with a wide phase dispersal ([Fig. 4C](#fig4-0748730414520663){ref-type="fig"}), and they also exhibited a high coefficient of variance for their period ([Table 1](#table1-0748730414520663){ref-type="table"}). Importantly, the cellular periods were not significantly affected by the presence of the *Tau* allele (heterozygote 25.5 + 1.4 h, homozygotes 24.6 + 1.1 h) when compared to *Tau* WT *Per1/2-*null SCN (1-way ANOVA *p* \> 0.05), but as with the *Per*-null *Tau* WT, the *Per-*null *Tau* heterozygote and homozygote slices had significantly higher period variance when compared to the PER-proficient control SCN ([Table 1](#table1-0748730414520663){ref-type="table"}).

Discussion {#section7-0748730414520663}
==========

The aim of this study was to explore the relative contributions of endogenous PER1, PER2, and PER3 to circadian pacemaking and as targets of the CK1ϵ^*Tau*^ mutation. It shows that both PER1 and PER2 are individually competent to sustain circadian behavior and molecular rhythms in the SCN. In contrast, PER3 cannot support clock function in the absence of PER1 and PER2. Both PER1 and PER2 are subject to the period-accelerating effects of *Tau*. Indeed, a single allele of either *Per1* or *Per2* can maintain clock function and show a shortened period in a *Tau* background. The effectiveness of the *Tau* allele was not affected by the number of *Per* alleles (i.e., there was no effect of the relative doses of PER and *Tau*). At the level of individual neurons, weak oscillatory behavior in the circadian range was detected in PER1/PER2-deficient SCN, but it was poorly defined, not synchronized among cells within a slice, and not sensitive to the *Tau* mutation. Thus, at all levels of analysis (whole animal, SCN slice, and individual SCN neurons), endogenous PER1 and PER2 are necessary and mutually redundant components of circadian pacemaking and mediators of the period-accelerating effect of the CK1ϵ^Tau^ mutation. Moreover, a weak PER- and *Tau*-independent oscillator within the circadian domain can be detected in SCN slices and cells.

In the current study, there was a close correspondence, among all genotypes, between the circadian rhythms measured in vivo and in vitro on *Per1-*null and *Per2-*null genetic backgrounds. This contrasts with the report that endogenous rhythms in *Per1-*null mutant SCN do not represent circadian behavior in vivo ([@bibr23-0748730414520663]): specifically, SCN from *Per1-*null mice, carrying a *Per1-luc* reporter, were poor oscillators at tissue and cellular levels, even though such mice were behaviorally rhythmic. Ruan et al. ([@bibr27-0748730414520663]) also reported poor circadian rhythms in *Per1*-null SCN, but rhythms could be established by a change of medium. These results contrast, however, with another report that is consistent with the present study, in which PER1-deficient SCN comprised perfectly effective circadian pacemakers ([@bibr14-0748730414520663]). The conflicting results may arise because of the age at which SCN slices were made: Pendergast et al. worked with postnatal mice "aged 25-204 d (mean ± SD: 65.2 ± 38.4 d)," whereas in the present study, SCN were made from neonatal pups (all younger than 14 days). Liu et al., however, stated that "SCN slices prepared from early postnatal (2-7 days old) or adult animals (1-4 months old) produced highly comparable rhythms for all genotypes."

PER1/PER2 double-null mice were behaviorally arrhythmic, and their SCN were either totally arrhythmic or exhibited transient short-period oscillations, likely initiated by medium change. Given that PER3 continues to be expressed in the absence of PER1 and PER2, albeit arrhythmically ([@bibr13-0748730414520663]), this confirms our earlier conclusion ([@bibr2-0748730414520663]) that endogenous PER3 is not able to sustain circadian behavior, and that PER1 and PER2 are necessary but mutually redundant clock components in the SCN. We cannot exclude the possibility, however, that PER3 contributes to circadian control in other tissues. Indeed, [@bibr24-0748730414520663] provided compelling data that loss of PER3, in the presence of both PER1 and PER2, can shorten the circadian period in vitro and advance the circadian phase in vivo of some peripheral tissues.

The mutual redundancy between PER1 and PER2 in supporting circadian pacemaking contrasts markedly with the differential contributions of CRY1 and CRY2 to circadian rhythms in vivo and in vitro. Specifically, loss of CRY1 accelerates the clock, whereas loss of CRY2 lengthens the period ([@bibr29-0748730414520663]). Stabilization of either CRY in the Fbxl3 Afterhours mutant further lengthens the circadian period ([@bibr1-0748730414520663]). These effects were interpreted from the viewpoint that both proteins are negative transcriptional regulators, but CRY2 is the weaker partner and is also able to attenuate the stronger actions of CRY1 when both proteins are present. No comparable effects on period are seen, however, with individual loss of the PER proteins. Insight into a possible molecular basis for the differential roles of CRY1 and CRY2 came from the demonstration that their access to E-box sequences occurred at different phases of the circadian molecular cycle ([@bibr12-0748730414520663]). Specifically, CRY2 binds earlier in the phase of negative feedback than does CRY1 (a difference of approximately 8 h in respective peak phases), and its presence may well delay access of CRY1 to the E-boxes, thus attenuating the molecular effects of CRY1. Consistent with their mutual redundancy, however, [@bibr12-0748730414520663] showed that the peaks of access to E-boxes for PER1 and PER2 were almost overlapping (phase difference of ca. 1.4 h). These observations thereby provide indirect evidence that whereas CRY1 and CRY2 perform significantly different tasks in the circadian molecular cycle, the actions of PER1 and PER2 are closely aligned in time and function.

The presence of weak circadian oscillations in *Per1/2-*null SCN neurons was comparable to reports of similar oscillations in *Cry1*/*2*-null ([@bibr16-0748730414520663]; [@bibr22-0748730414520663]) and *Bmal1*-null SCN ([@bibr11-0748730414520663]). Although transient at the level of the SCN slice and poorly synchronized between cells within a slice, they reveal the presence of an underlying oscillatory or resonant structure that is independent of both the positive and negative limbs of the conventional E-box--dependent circadian transcriptional feedback loop ([@bibr12-0748730414520663]). The presence of calcium- and cyclic AMP−responsive elements (CREs) in the promoters of the *Per1-luc* and PER2::luc reporters used to reveal these oscillations is consistent with the view that calcium- and cAMP-dependent cytosolic signaling pathways that converge onto these elements have intrinsic periodicity, independent of the transcriptional loop ([@bibr8-0748730414520663]; [@bibr11-0748730414520663]). A critical role of interneuronal signaling is to engage these cytosolic pathways and thereby mutually synchronize the transcriptional feedback loops of all cells throughout the SCN ([@bibr21-0748730414520663]; [@bibr14-0748730414520663]; [@bibr3-0748730414520663]). The loss of transcriptional regulators intrinsic to the loop will destabilize the loop directly. It will also destabilize it indirectly by compromising transcriptional regulation of these interneuronal signals and the cytosolic inputs that they, in turn, drive. Hence, the *Per1-luc* rhythms observed in *Per1/2-*null SCN neurons are poorly defined and desynchronized, although they are subject to transient re-initiation by medium change, which will activate the intrinsically rhythmic cytosolic signaling pathways. This likely involves calcium- and cAMP-dependent cascades, but there remains the possibility that acutely induced cellular rhythms of adenosine triphosphate availability arising from PER-independent circadian changes in the metabolic state would also lead to rhythms in bioluminescence separately from any changes in luciferase abundance ([@bibr6-0748730414520663]).

The central role of CK enzymes and PER proteins in setting the speed of the circadian pacemaker has been established by genetic, biochemical, and pharmacological approaches in experimental models. Moreover, the causation of familial advanced sleep phase syndromes by mutations in hCK1 and hPER2 emphasizes their relevance to human health ([@bibr10-0748730414520663]; [@bibr28-0748730414520663]; [@bibr31-0748730414520663]). The current results obtained by a genetic approach, accompanied by dynamic measures of circadian pacemaking in SCN slices and cells, complement and extend earlier biochemical studies that focused on PER-CK1 interactions between recombinant proteins in cell lines and endogenous proteins in ex vivo peripheral tissues. Specifically, both endogenous PER1 and PER2, but not PER3, are effective in vivo mediators of circadian period shortening by CK1ϵ^*Tau*^. There was, however, a trend in vitro for a PER2-dependent (i.e., *Per1-*null) SCN to be more sensitive to the mutation than a PER1-dependent (*Per2*-null) SCN (4.5 vs. 2.9 h, respectively). It may therefore be the case that other factors (e.g., retinal and brain stem afferents to the SCN) modify the function of the SCN in vivo, with their absence unmasking this PER1-versus-PER2 difference in vitro. In this regard, it would be of interest to determine the effects of *Tau* on the stability of PER1 and PER2 in the SCN (currently reported solely for PER2; [@bibr18-0748730414520663]). Aside from this limited effect, there was no significant contrast between the PER paralogs in their contribution to pacesetting. As for PER3, its particular role in circadian pacemaking remains difficult to define. It is clear that polymorphisms in *hPer3* can influence diurnal preference, but this is likely related to an effect on sleep homeostasis rather than circadian function per se ([@bibr30-0748730414520663]). Consistent with the biochemical evidence that PER3 is unable directly to interact with CK1ϵ ([@bibr13-0748730414520663]), our in vivo and in vitro results exclude endogenous PER3 both as an essential circadian factor in the SCN and as a mediator of CK1ϵ^*Tau*^ actions.

Finally, our observation that the *Tau* mutation can accelerate the clock of mice via actions on PER2 is consistent with the report that a mutation in hPER2 that affects the binding with, and phosphorylation by, WT CK1ϵ shortens the circadian period and leads to a sleep phase disorder ([@bibr28-0748730414520663]). In a previous study, inhibitors of CK1δ/ϵ were shown to slow the circadian clock of both WT and *Tau* mutant mice, and in the latter case they can correct the period of the homozygous mutant SCN to WT (i.e., cause a deceleration of 4 h) ([@bibr19-0748730414520663]). Thus, the development of compounds that affect CK1δ/ϵ function directly, or alter the ability of either PER1 or PER2 to interact with CK1δ/ϵ, may provide a suitable means to control aberrant circadian period or disrupted entrainment arising from genetic or environmental (e.g., rotational shiftwork) perturbations.
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